Allspring Global Investments
INO icon

Allspring Global Investments’s Inovio Pharmaceuticals INO Stock Holding History

Allspring Global Investments’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,545
Closed -$29.7K – 2841
2023
Q2 		$29.7K Buy
+5,545
New +$44.7K ﹤0.01% 2403
2022
Q2 		– Sell
-3,763
Closed -$162K – 2805
2022
Q1 		$162K Sell
3,763
-416
-10% -$18.7K ﹤0.01% 2636
2021
Q4 		$250K Buy
+4,179
New +$335K ﹤0.01% 2570

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Allspring Global Investments's INO Position: Q3 2023 in Review

Allspring Global Investments sold out of Inovio Pharmaceuticals (INO) in Q3 2023, closing a stake of 5,545 shares — an estimated $29.7K sold.

Allspring Global Investments first reported a position in INO in Q4 2021 and held it in 3 quarters. The position peaked at $250K in Q4 2021. 124 funds tracked by Wall St. Rank hold INO as of Q3 2023.

  • Allspring Global Investments reported no remaining Inovio Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Allspring Global Investments sold 5,545 Inovio Pharmaceuticals shares in Q3 2023, an estimated $29.7K.
  • Allspring Global Investments first reported a position in Inovio Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Allspring Global Investments's Inovio Pharmaceuticals position peaked at $250K in Q4 2021.
  • 124 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2023.

Based on Allspring Global Investments's 13F filing for Q3 2023, filed 27 Oct 2023.